Iron Overload - 26 Studies Found
Completed |
: A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity : Transfusional Iron Overload : 2010-01-05 : Drug: ICL670 |
Completed |
: A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload : Transfusion-dependent Iron Overload : 2005-09-13 : Drug: Deferasirox Other Name: ICL670 |
Terminated |
: Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation Therapy : Iron Overload Due to Repeated Red Blood Cell Transfusions : 2012-05-22 : Drug: SPD602 50 mg/kg/day orally twice daily for 24 weeks |
Completed |
: An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload : Transfusional Iron Overload in β-thalassemia : 2005-09-12 : Drug: Deferasirox Tablets taken orally once a day. |
Completed |
: Iron Overload in African Americans :
: 1999-11-03 |
Completed |
: Cytochrome P450 2E1 and Iron Overload :
: 2005-08-29 : Procedure: venesection Venesection therapy is realised every 7 - 14 days until iron desaturation complet |
Completed |
: Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients :
: 2011-05-17 :
|
Completed |
: Retrospective Evaluation of Adult and Pediatric Transfusion-dependent Patients Treated With Deferasirox Therapy : Iron Overload : 2013-05-26 |
Completed |
: Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major :
: 2011-07-11 : Drug: Amlodipine 5mg PO initially; may be reduced to 2.5mg PO if side effects |
Recruiting |
: Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis :
|